Recently, Steen et al proposed a two-stage approach for genome-wide family-based association studies. In the first stage, a screening test is used to select markers, and in the second stage, a family-based association test is performed on a much smaller set of the selected markers. The two-stage method can be much more powerful than the traditional family-based association tests. In this article, we extend the approach so that it can incorporate parental information and can be applied to an arbitrary pedigree structure. We use simulation studies to evaluate the type I error rates and the power of the proposed methods. Our results show that the two-stage approach that incorporates founders' phenotypes has the correct type I error rates, and is much more powerful than the two-stage approach that uses children's phenotypes only. Also, by carefully choosing the number of markers retained in the first stage, the power of a two-stage approach can be much more than that of the corresponding one-stage approach.
Introduction
Rapid progress in high-throughput genotyping technologies has greatly reduced the cost of genome-wide analyses and is resulting in a boom of large-scale genetic association studies on common disorders. Genome-wide association studies are now widely used approaches in the search for loci that affect complex traits. While genome-wide association studies are promising to mapping complex disease genes, 1 -3 their success will depend on whether the information gain of the increased number of SNPs will be diluted by the multiple-comparison problem. 1 When hundreds of thousands of SNPs are tested for association, the P-values need to be adjusted for controlling type I error rates. Most multiple-testing adjustment approaches, including the Bonferroni correction for controlling familywise error rate and the method proposed by Benjamini and Hochberg 4 for controlling false discovery rate (FDR), become more conservative as more tests are performed. In case -control studies, several authors have proposed a two-stage design that utilizes two samples. 5, 6 The first sample is used to screen and select SNPs for association tests. The association tests are conducted on the selected SNPs by using the second sample, so that the number of association tests is diminished and the correction for multiple testing is less severe. To avoid biased test results, the sample used in the screening step should be independent of the sample used for association testing. For family data, it is possible to create two sources of information using one sample. 7 Recently, in mapping quantitative trait loci using family data, 
Methods
For the two-stage approaches, if the association test used in the second stage is robust to population admixture, then the two-stage approach will be robust to population admixture regardless of the screening test used in the first stage. Because the number of markers returned in the first step, denoted by L, is fixed in advance and the critical value at the stage is set accordingly, even if the set of L markers tested in the second stage includes a high proportion of false positives due to population stratification, the proportion of those that pass the second stage is not inflated by population stratification and the overall probability that a marker would pass both stages is the nominal test size. In this section, we will propose two twostage approaches for genome-wide family-based association studies. We will first describe the QPDT, the association test used in the second stage for both the two proposed two-stage approaches.
QPDT: the association test used in the second stage The TDT 9 and its extensions for qualitative traits 10 -14 and quantitative traits 15 -19 Assume that there are n pedigrees, n i informative nuclear families in the ith pedigree, and n ij children in the jth informative nuclear family of the ith pedigree. Consider a biallelic marker with two alleles 0 and 1. We use the following notation:
Y ijF ,Y ijM , and Y ijk : the trait value of the father, mother, and the kth child in the jth informative nuclear family of the ith pedigree, respectively. X ijF , X ijM , and X ijk : the genotypic score (number of copies of alleles 1) of the father, mother, and the kth child in the jth informative nuclear family of the ith pedigree, respectively. Ȳ and X: The average trait value and average genotypic score of all the individuals, respectively. X ij : If parental genotypes are available (the first type of informative nuclear families), X ij ¼ ðX ijF þ X ijM Þ=2 ; otherwise (the second type of informative nuclear families),
By using the notation, the statistic of the QPDT is given by
where
Under the null hypothesis of no linkage disequilibrium, the QPDT asymptotically follows a standard normal distribution. We can think of random variables U ij as the covariance between the children's trait values and within-family genotypic score, X ijk À X ij : The QPDT only uses the within-family genotype information, and thus is robust to population admixture.
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The screening tests used in the first stage Although the QPDT only uses informative nuclear families, the screening tests can use all the nuclear families in a pedigree. Let N i denote the number of nuclear families in the ith pedigree. The two screening test statistics are in the same form as the QPDT statistic. Both the two screening test statistics can be written as
However, U ij are different in the two tests. The definitions of U ij in the two tests are given below:
1. In the first screening test, which uses children's phenotypes only,
In this case, the corresponding two-stage approach is called a two-stage test using children's phenotypes only (TTCPO). 2. In the second screening test, which uses children's phenotypes as well as the phenotypes of founders of the pedigrees,
where I ijF ¼ 1 if the father of the jth family in the ith pedigree is a founder of this pedigree; otherwise, I ijF ¼ 0 and I ijM is similarly defined for the mother. In this case, the corresponding two-stage approach is called a twostage test using founder's phenotypes (TTFP).
Under the null hypothesis of no association, both the screening test statistics follow a standard normal distribution.
Applying the two-stage approaches to genome-wide association studies Suppose that M SNPs have been genotyped for each sampled individual. In the first stage, we use one of the screening tests to test each of the M SNPs. Select L SNPs with the smallest p-values, where L is a pre-specified number (we will discuss how to choose L later). In the second stage, we apply the QPDT to the L selected SNPs, and declare an SNP as significant at a level of a if the pvalue of the QPDT at this marker is less than a threshold d La . The threshold d La is determined by controlling the FDR, the ratio of the number of falsely rejected null hypotheses to the total number of rejected null hypotheses, at a level of a. To control the FDR at a level of a, we can choose the cutoff d La as follows: 4 let p (1) , y, p (L) be the ordered p-values when we apply the PDT to the L selected markers; then
Results
We use simulation studies to evaluate the performance of the proposed methods. In the simulations, we consider two family structures. The first one is a nuclear family with one child; the second one is a three generation pedigree as given in Figure 1 . This family structure is one of the Centre d'Etude du Polymorphism Humans (CEPH) pedigrees. 20 For each family structure, we use two approaches to generate genotype data. In the first approach, we generate the genotypes of the founders by assuming Hardy -Weinberg equilibrium and linkage equilibrium. Each founder randomly transmits one of his/her two alleles to form the children's genotypes. This means that we generate each allele and each marker independently. The frequency of the minor allele at each marker is a random number between 0.05 and 0.45.
In the second approach, we want to mimic the linkage disequilibrium (LD) structure of real data sets. To generate the genotypes with LD between markers, we use Hudson's ms program, 21 which assumes the coalescent process with recombination to generate multi-marker haplotypes. We follow Nordborg M, Tavare S, 22 and Kimmel G and Shamir R, 23 using a mutation rate of 2.5 Â 10 À8 per nucleotide per generation, a recombination rate of 10 À8 per pair of nucleotides per generation, and an effective population size of 10 000. Of all the segregating sites, only the ones with a minor allele frequency 45% are defined as SNPs and are used in the rest of the analysis. The simulation program produces populations of haplotypes from which genotypes of the founders in each pedigree can be generated. The genotypes for each individual who is not a founder can be formed by her/his parents. Figure 1 The pedigree structure used in the simulation studies. To generate trait values of all individuals in a pedigree, we first generate the trait value of each founder by using a standard normal distribution. The trait values of the other members can be generated by a normal distribution with a mean vector of m c and variance -covariance matrix of P c , given the trait values of their parents.
We consider sample sizes of 200, 400, 600, and 800 for nuclear families, and sample sizes of 50, 100, 200, and 300 for large pedigrees. We also consider three different numbers of markers: 1000, 10 000, and 100 000. For each simulation scenario, we generate 1000 samples to estimate type I error rates of the two two-stage approaches by using different values of L (the number of markers retained in the first stage). Note that when L ¼ M (the total number of markers), the two-stage approach is equivalent to the onestage approach. For 1000 replications, the 95% confidence interval of type I error rate is (0.0362, 0.0638) for the nominal level of 5%. The type I error results based on genotypes generated under Hardy -Weinberg equilibrium are similar to those based on genotypes generated by ms program. 21 We only report the results based on genotypes generated by ms program. The estimated type I error rates are summarized in Table 1 for nuclear families and Table 2 for large pedigrees. The two tables show that the type I error rates of the TTCPO and TTFP are very consistent with the nominal level of 5% for a small value of L and little more conservative for a larger L. The conservativeness of type I error rates for a large value of L is because of the conservative nature of multiple test adjustments by controlling the FDR. The type I error rates for the TTCPO and TTFP also show that the screening tests used in the first stage and the PDT used in the second stage are independent.
Power comparisons
For power comparisons, we first generate genotype data as described in the previous section and then generate trait values according to different disease models as described below. For a pedigree with K members, let e 1 ,y,e K be the trait values of the K members generated under the null hypothesis using the method described in the previous section. Assume that the disease locus is a biallelic marker with two alleles D and d. Then, the trait value of the kth member is given by
where x k1 is the additive genotypic score, that is, x k1 ¼ À1, 0, or 1 corresponding to genotypes dd, Dd, or DD of the kth 
where p denotes the allele frequency of allele D at the disease locus.
In our simulations, we generate genotypes at 100 000 markers for each individual by either one of the two generating methods, and vary the value of L (the number of markers retained in the first step) from 1 to 100 000. The results of L ¼ 100 000 are the results of the one-stage approach, the PDT. We consider different sample sizes, different disease models, and different values of heritability h. For each scenario, we use 1000 replicated samples to estimate the power of the tests. To reduce the effect of allele frequency at the disease locus, we randomly choose a marker with minor allele frequency between 0.1 and 0.4 as a disease locus for each replication.
The patterns of power comparisons are similar under the three disease models. We use the additive model as an example to describe the results. The power comparisons of the TTPCO and TTFP are given in Figure 2 for nuclear families and in Figure 3 for large pedigrees. The two figures show powers based on genotype data generated by using ms software. h denotes the heritability.
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show that the TTFP, which uses the founders' phenotypes consistently outperforms the TTCPO for all the scenarios we considered. In most cases, the power of the TTFP is substantially more than that of the TTCPO. For example, the power of the TTFP is 70% while the power of the TTCPO is 10% when the sample contains 800 nuclear families and the heritability h ¼ 0.03, the number of markers retained in the first stage L ¼ 1, and the genotypes are generated under the assumptions of the HardyWeinberg equilibrium and the linkage equilibrium. Comparing the two two-stage approaches with the one-stage approach, that is the QPDT, by carefully choosing L, both of the two-stage approaches are more powerful than the one-stage approach in all the cases. However, the power of the two-stage approaches depends on L, the number of markers retained in the first stage, and the optimal value of L depends on the LD structure of the genotypes. 
Discussion
The main purpose of this article is to extend the two-stage method proposed by Steen et al 1 so that the method can Two-stage family-based association tests T Feng et al incorporate parental information and can be easily applied to large pedigree data. For this purpose, we proposed two two-stage approaches, the TTCPO and TTFP. The basic assumption to guarantee the correct type I error rates of a two-stage approach is that the test used in the first stage is statistically independent of the test used in the second stage. The TTCPO, which uses children's phenotypes only, and the TTFP, which uses phenotypes of children as well as the founders in the pedigrees, have correct type I error rates in all the cases we considered. We further compare the power of the two valid approaches, the PPCPO and TTFP. Our results show that by incorporating the founders' phenotypes, the TTFP is consistently more powerful than the PPCPO. In some cases, the power of the TTFP is several times more than that of the PPCPO. Although most of genome-wide association studies use a case -control design, genome-wide family-based association studies are still necessary. 24 Family-based genomewide association studies usually use nuclear families extracted from pedigrees of previous linkage studies. The phenotype data of the nuclear families from previous linkage studies often include parental phenotypes. In this case, our proposed TTFP is feasible and more powerful than the method proposed by Steen et al. 1 Although general pedigrees have not been seen in genome-wide association studies, they may be used in the follow-up studies, and thus our method is necessary. One remaining question is choosing the value of L, the maximum number of markers retained in the first stage. Our simulation results show that there is no unique answer in choosing an optimal L. If there is weak LD between adjacent markers, the values between 10 and 20 may be a good choice for L. If there is strong LD between adjacent markers, the optimal value of L should be much larger, 100 -500 as suggested by our simulation study. In conclusion, we need further investigations on choosing the optimal value of L.
